Toward a Definition of Sarcopenia

被引:60
作者
Cederholm, Tommy E. [1 ,2 ]
Bauer, Juergen M. [3 ]
Boirie, Yves [4 ,5 ]
Schneider, Stephane M. [6 ]
Sieber, Cornet C. [7 ]
Rolland, Yves [8 ,9 ]
机构
[1] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75185 Uppsala, Sweden
[2] Univ Hosp, Dept Geriatr, S-75185 Uppsala, Sweden
[3] GZO, Klin Geriatrie, D-26133 Oldenburg, Germany
[4] Univ Hosp Clermont Ferrand, Dept Clin Nutr, F-63003 Clermont Ferrand, France
[5] Human Nutr Unit, F-63009 Clermont Ferrand, France
[6] Univ Nice Sophia Antipolis, Nutr Support Unit, Archet Univ Hosp, F-06205 Nice, France
[7] Univ Erlangen Nurnberg, Inst Biomed Aging, D-90419 Nurnberg, Germany
[8] Univ Toulouse 3, Inserm U1027, F-31073 Toulouse, France
[9] Toulouse Univ Hosp, F-31300 Toulouse, France
关键词
Sarcopenia; Muscle mass; Aging; Cachexia; SKELETAL-MUSCLE MASS; OBSTRUCTIVE PULMONARY-DISEASE; LOWER-EXTREMITY FUNCTION; PHYSICAL PERFORMANCE BATTERY; BODY-COMPOSITION; OLDER PERSONS; ELDERLY-MEN; HEALTH ABC; GAIT SPEED; STRENGTH;
D O I
10.1016/j.cger.2011.04.001
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The definition of sarcopenia has been thoroughly discussed by scientific stakeholders and industry representatives to increase the clinical applicability of the concept. The pooled consensus from 3 of 5 recent and parallel processes, of which 2 are pending, is that sarcopenia is mainly, but not only, an age-related condition defined by the combined presence of reduced muscle mass and muscle function. Contributing factors to sarcopenia are senescence, chronic disease, physical inactivity, and poor food intake. Cachexia may be considered as one etiologic pathway of an accelerated sarcopenia. The adjusted and extended definitions of sarcopenia promote the clinical use of the concept.
引用
收藏
页码:341 / +
页数:14
相关论文
共 70 条
[1]   Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure [J].
Anker, SD ;
Ponikowski, PP ;
Clark, AL ;
Leyva, F ;
Rauchhaus, M ;
Kemp, M ;
Teixeira, MM ;
Hellewell, PG ;
Hooper, J ;
Poole-Wilson, PA ;
Coats, AJS .
EUROPEAN HEART JOURNAL, 1999, 20 (09) :683-693
[2]  
[Anonymous], WORLD POP AG 1950 20
[3]  
Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.3.CO
[4]  
2-E
[5]   STIMULATION OF MUSCLE PROTEIN-DEGRADATION AND PROSTAGLANDIN-E2 RELEASE BY LEUKOCYTIC PYROGEN (INTERLEUKIN-1) - A MECHANISM FOR THE INCREASED DEGRADATION OF MUSCLE PROTEINS DURING FEVER [J].
BARACOS, V ;
RODEMANN, HP ;
DINARELLO, CA ;
GOLDBERG, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (10) :553-558
[6]  
Baracos VE, 2001, CANCER, V92, P1669, DOI 10.1002/1097-0142(20010915)92:6+<1669::AID-CNCR1495>3.0.CO
[7]  
2-S
[8]   Epidemiology of sarcopenia among the elderly in New Mexico [J].
Baumgartner, RN ;
Koehler, KM ;
Gallagher, D ;
Romero, L ;
Heymsfield, SB ;
Ross, RR ;
Garry, PJ ;
Lindeman, RD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (08) :755-763
[9]   Predictors of skeletal muscle mass in elderly men and women [J].
Baumgartner, RN ;
Waters, DL ;
Gallagher, D ;
Morley, JE ;
Garry, PJ .
MECHANISMS OF AGEING AND DEVELOPMENT, 1999, 107 (02) :123-136
[10]   Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients [J].
Biolo, G ;
Bosutti, A ;
Iscra, F ;
Toigo, G ;
Gullo, A ;
Guarnieri, G .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (06) :689-691